8-K: Neuraxis Declares Series B Preferred Stock Dividend

Neuraxis, Inc. announced a stock dividend for its Series B Preferred Stock, payable in common stock on July 29, 2026.

Summary

• Neuraxis, Inc. declared a stock dividend for its Series B Preferred Stock for the second quarter of 2026.
• The dividend will be paid in shares of the Company's common stock.
• The number of common shares issued will be based on accrued and unpaid dividends on Series B Preferred Stock from April 1, 2026, to the record date, divided by $2.38 per share.
• Approximately 80,463 shares of common stock are expected to be issued.
• Holders entitled to fractional shares will receive cash instead, calculated as $2.38 multiplied by the fractional share entitlement.
• The dividend is payable on July 29, 2026, to shareholders of record as of July 21, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it addresses preferred shareholder dividends, the issuance of common stock implies potential dilution for common shareholders and may signal underlying financial considerations for the company.

Positives

• Declaration of a stock dividend on Series B Preferred Stock, indicating potential return to preferred shareholders.
• The dividend is to be paid in common stock, which could increase the float and liquidity of the common shares.
• A specific expected issuance of approximately 80,463 common shares provides a quantifiable impact.

Negatives

• The dividend is paid in common stock, which dilutes existing common shareholders.
• The dividend is based on accrued and unpaid dividends, suggesting potential past financial strain or dividend arrears.
• The cash payout for fractional shares, while practical, represents a cash outflow for the company.

Risks

• Potential dilution of common stock value due to the issuance of new shares.
• The need to pay dividends on preferred stock may indicate ongoing financial obligations that could impact future growth or operations.
• The fixed conversion price of $2.38 for the dividend calculation could be a point of contention if the common stock price fluctuates significantly.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the declaration and payment of the current stock dividend.

Industry Context

StockSavvy.ai notes that dividend declarations, especially stock dividends, are common corporate actions. The specifics of this dividend, paid in common stock for preferred shares, suggest a strategy to manage preferred shareholder returns while potentially conserving cash or increasing common stock liquidity. The fixed conversion value of $2.38 is a key metric to monitor against the prevailing common stock price.

Stakeholder Impact

• Common Shareholders: May experience dilution in ownership percentage and potential decrease in share value due to the issuance of new shares.
• Series B Preferred Stockholders: Will receive a dividend in common stock, increasing their equity stake in the company, or cash in lieu of fractional shares.
• The Company: Will issue approximately 80,463 shares of common stock and potentially make cash payments for fractional shares, impacting its equity structure and cash reserves.

Next Steps

• Payment of the stock dividend on July 29, 2026.
• Distribution of common stock shares and cash in lieu of fractional shares to Series B Preferred Stock holders.

Key Dates

Keywords

Neuraxis, Inc., 8-K, Stock Dividend, Series B Preferred Stock, Common Stock, Dividend Payment, SEC Filing, Corporate Action